HAI Book 2025 - Flipbook - Page 299
Board 88
Board 89
Board 90
Board 91
Board 92
Board 93
Board 94
Board 95
Board 96
Board 97
Board 98
Board 99
Differential tau
accumulation in early-onset
and late-onset Alzheimer's
disease: Insights from
[18F]-Florzolotau PET
Heterogeneity of FDG-PET
patterns among taunegative amnestic patients
Predicting amyloid
positivity and tau burden in
dementia using a
combination of different
biomarkers
Evaluation of [³H]SynVesT 1 binding in post-mortem
brain tissue from control
and Alzheimer9s Disease as
a biomarker of synaptic loss
Exploring the predictive
power of graph-theoretic
metrics for tau pathology in
cognitively unimpaired
older adults
Tracking biomarkers
accuracy for predicting
progression to mild
cognitive impairment
Tau burden across Braak
stages is associated with
regionally specific amyloid
accumulation: insights from
the BIOCARD cohort
Relationship between
neuroinflammatory ER176PET and functional
connectivity in Progressive
Apraxia of Speech
Sex moderates the
association between
regional tau and longitudinal
cognitive decline in A4 and
LEARN studies
Evaluation of the Uni-tau
and CenTauR frameworks in
new datasets for tau PET
harmonization in
Alzheimer9s disease
Hemispheric lateralization
of tau-related network
dysfunction and its
association with
neuropsychiatric symptoms
in preclinical Alzheimer9s
disease
Characterization and
correction of extracerebral
[18F]MK-6240 tau PET offtarget signal in Alzheimer's
disease
Khurelbaatar | Huang | Lin | Huang |
Hsu | Huang | Wu | Huang | Chang |
Hsiao
Silva-Rodríguez | Moscoso |
Labrador-Espinosa | Sánchez-Juan |
Scholl | Grothe
Bayarjargal Khurelbaatar,
Department of Medical Imaging and
Radiological Sciences, Chang Gung
University, Taoyuan, Taiwan, ROC.,
Taoyuan, TW
Jesús Silva-Rodríguez, Reina Sofia
Alzheimer Centre, CIEN Foundation,
ISCIII, Madrid, ES
Huang | Lin | Huang | Huang | Wu |
Chang | Hsiao
Shao-Yi Huang, Department of
Medical Imaging and Radiological
Sciences, Chang Gung University,
Taoyuan, TW
Kulagowska | Lemoine | King |
Gladstein | Bevis | Bonsall | Finnema |
Spires-Jones | Wells | SV2A project
team
Laura Kulagowska, Perceptive,
London, GB
Johns | Vin | Abuwarda | Fredericks
Emily Johns, Department of
Neurology, Yale University School of
Medicine, New Haven, CT, US
Gallego-Rudolf | Wiesman | Baillet |
Villeneuve
Jonathan Gallego-Rudolf, Douglas
Research Centre, Montreal, QC, CA
Rani | Alm | Callow | Pettigrew | Soldan
| Miller | Albert | Bakker
Nisha Rani, Department of
Psychiatry and Behavioral Sciences,
Johns Hopkins University School of
Medicine, Baltimore, MD, US
Singh-Reilly | Sintini | Satoh | Duffy |
Utianski | Clark | Stephens | Lowe |
Josephs | Whitwell
Neha Singh-Reilly, Department of
Neurology, Mayo Clinic, Rochester,
MN, US
Li | Klinger | Seto | Birkenbihl | Farrell |
Thibault | Rissman | Properzi | Schultz
| Townsend | Yang | Johnson | Reman |
Langford | Donohue | Sperling |
Buckley | Coughlan
Annie Li, Department of Neurology,
Massachusetts General Hospital,
Harvard Medical School, Boston, MA,
US
Lutz | Olafson | Tonietto | Klein |
Pascoal | Negrini | Povala | Leuzy |
Raket | Doren | Sanabria Bohorquez |
Teng
Olivia Lutz, Research and Early
Development (gRED), Genentech,
Inc, South San Francisco, CA, US
Moret | Vin | Fredericks
Sophia Moret, Yale University, New
Haven, CT, US
Olafson | Tonietto | Doren | Sanabria
Bohórquez
Emily Olafson, Research and Early
Development (gRED), Genentech,
Inc., South San Francisco, CA, US
HAI2025 - 299
